This content is only available within our institutional offering.
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Ideagen - Low risk and high activity in risk management
- Published:
22 Jan 2019 -
Author:
Andrew Darley -
Pages:
12
Interims are in line with guidance, as ever, including a boost in activity across the group, particularly SaaS and the US. 8% organic revenue growth was complemented by 67% recurring revenue (FY18: 62%), growing cash generation, and a continuing strong track record of acquisitions. The board structure implemented for FY19 is proving its worth, in delivering continuing operational excellence in addition to strategic acquisitions as the Integrated Risk Management market consolidates. Clients won in the period – household names including GlaxoSmithKline and McLaren Mercedes – reiterate product quality. Target 180p reiterated as Ideagen continues to lead the sector by example.